Quick Answer
Opus Genetics, Inc. reported Total Assets of $50.24 million for fiscal year 2025.
Opus Genetics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $50.24M | +36.3% |
| 2024 | $36.86M | -31.7% |
| 2023 | $53.95M | +10.1% |
| 2022 | $48.99M | +87.9% |
| 2021 | $26.08M | +47.5% |
| 2020 | $17.68M | +891.1% |
| 2019 | $1.78M | -88.9% |
| 2018 | $16.04M | -43.3% |
| 2017 | $28.29M | +34.4% |
| 2016 | $21.04M | -15.2% |
| 2015 | $24.81M | -26.0% |
| 2014 | $33.53M | +71.5% |
| 2013 | $19.56M | +31.1% |
| 2012 | $14.92M | +9.0% |
| 2011 | $13.69M | -15.6% |
| 2010 | $16.22M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $36.12M | -10.6% | -6.6% |
| June 30, 2025 | $38.66M | -13.8% | -19.7% |
| March 31, 2025 | $48.17M | -7.1% | +30.7% |
| December 31, 2024 | $36.86M | -31.7% | -8.7% |
| September 30, 2024 | $40.39M | -25.5% | -9.9% |
| June 30, 2024 | $44.83M | +3.1% | -13.5% |
| March 31, 2024 | $51.84M | +14.2% | -3.9% |
| December 31, 2023 | $53.95M | +10.1% | -0.4% |
- Opus Genetics, Inc. showed an increase of +36.3% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, Opus Genetics, Inc.’s total assets has grown by 209.8% (from $16.22 million to $50.24 million).
- The most recent figure is from Opus Genetics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: